Who are Amaroq Therapeutics's investors?

Amaroq Therapeutics's investors include Booster Innovation Fund, Cure Kids Ventures, Tenmile, Brandon Capital Partners.

Amaroq Therapeutics

6 employees on LinkedIn · 4 known investors

Find your way into Amaroq Therapeutics

Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases. The company uses proprietary platforms to discover, validate, and create precision medicines against disease-relevant lncRNAs, focusing initially on oncology programs with high unmet medical need.

Biotech

Investors · 4

Booster Innovation FundWellington

Cure Kids VenturesAuckland

Tenmile

Brandon Capital Partnersreported

In the news

Amaroq Success Story - Otago Innovationotagoinnovation.com · Nov 2023

Amaroq Therapeutics secures $14 million investment for new cancer drugbooster.co.nz · Oct 2023

NZ-based startup Amaroq Therapeutics secures funding to develop cancer treatmentsbiospectrumasia.com · Jul 2021

NZ RNA start-up secures significant investment to progress cancer research - Biotechbiotechdispatch.com.au · Jul 2021

$14m invested in world-leading RNA therapy: University of Otago spinout targeting new cancer treatments - Brandon Capitalbrandoncapital.vc · Jul 2021

Frequently asked questions

What does Amaroq Therapeutics do?: Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases. The company uses proprietary platforms to discover, validate, and create precision medicines against disease-relevant lncRNAs, focusing initially on oncology programs with high unmet medical need.
Who are Amaroq Therapeutics's investors?: Amaroq Therapeutics's investors include Booster Innovation Fund, Cure Kids Ventures, Tenmile, Brandon Capital Partners.